EGRP News Flash - March 27, 2009
New NIH Recovery Act Initiative: "Grand Opportunities" Grants Program for Research and Research Infrastructure
On March 23, 2009, the National Institutes of Health (NIH) announced a new grants program, RFA-OD-09-004, entitled Research and Research Infrastructure "Grand Opportunities" (GO). The purpose of the GO grants is to support high impact ideas that lend themselves to short-term, non-renewable funding, and which may lay the foundation for new fields of investigation. The program will support large-scale research projects that accelerate critical breakthroughs, early and applied research on cutting-edge technologies, and new approaches to improve the synergy and interactions among multi- and inter-disciplinary research teams.
NCI is one of the NIH Institutes and Centers with funding authority to participate in this funding announcement. Overall, NCI expects to devote $10,000,000 over two years to the GO program.
This initiative is one of several being offered by NIH Institutes and Centers (ICs) to help fulfill the goals of the American Recovery and Reinvestment Act (ARRA or "Recovery Act") to help stimulate the economy through support of biomedical and behavioral research.
The scope of the GO grants program includes, but is not limited to the following:
- Groundbreaking, innovative, high impact and cross-cutting research projects that can be readily deployed and that will improve and accelerate biomedical research.
- Basic, clinical and translational projects that could fundamentally enhance the research enterprise and that require the participation, interaction, coordination, and integration of activities carried out in multiple research laboratories.
- Creation of large scale unique resources, accelerated application of high throughput, and other novel technologies.
- Deployment of critical infrastructure, resources, tools, and methodologies that substantially accelerate collaborative, multi- and inter-disciplinary basic, translational, and/or clinical research.
- Implementation of large scale research projects that are carried out using new and creative collaborative agreements and partnerships with industry and small businesses to accelerate the pre-clinical and clinical testing of new therapeutics.
- Creative approaches to overcome barriers to basic, translational, or clinical research using novel tools, technologies, and services.
Letters of intent are due on April 27, 2009 and the application due date is May 27, 2009. On-time submission requires that applications be successfully submitted to Grants.gov no later than 5:00 p.m. local time (of the applicant's institution/organization).
- This NIH Web site
lists the URLs for the various IC GO grant Web pages.
NCI contacts, by topic, are:
- Nanotechnology - Piotr Grodzinski, Ph.D., 301-496-1550
- Proteomics - Henry Rodriguez, Ph.D., 301-496-1550
- Stem Cells - Allan Mufson, Ph.D., 301-496-7815
- Early Phase Clinical Trials - William Timmer, Ph.D., 301-594-9796
- Transcriptional and Translational Regulation - Judy Mietz, Ph.D., 301-496-9326
- Comparative Oncology Research - Suresh Mohla, Ph.D., 301-435-1878